前收市價 | 0.1300 |
開市 | 0.1300 |
買盤 | 0.1000 |
賣出價 | 0.1400 |
拍板 | 24.00 |
到期日 | 2024-08-16 |
今日波幅 | 0.1200 - 0.1300 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 8.59k |
Billionaire money managers have bought millions of shares of both Pfizer and Walgreens Boots Alliance this year.
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the mRNA vaccine maker’s efforts to reclaim pandemic profits from its competitors, the Financial Times reports. Although Pfizer has nine months to appeal the decision, the EPO’s writte
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.